Humanized antibodies to tnf-like ligand 1a (TL1a) and uses thereof

ZA202405649BActive Publication Date: 2026-08-26PROMETHEUS BIOSCIENCES INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ZA202405649
Authority / Receiving Office
ZA · ZA
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-10-24
Filing Date
2024-07-22
Publication Date
2026-08-26
Estimated Expiration
2044-07-22

Smart Images

  • Figure 00000296_0000
    Figure 00000296_0000
  • Figure 00000296_0001
    Figure 00000296_0001
  • Figure 00000296_0002
    Figure 00000296_0002
Patent Text Reader

Abstract

Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
Need to check novelty before this filing date? Find Prior Art